Loading clinical trials...
Loading clinical trials...
Stivarga® Regulatory Post-Marketing Surveillance Study in Korea
Conditions
Interventions
Regorafenib (Stivarga,BAY73-4506)
Locations
1
South Korea
Multiple Locations, South Korea
Start Date
June 25, 2014
Primary Completion Date
May 7, 2019
Completion Date
May 7, 2019
Last Updated
July 24, 2023
NCT06662786
NCT06663319
NCT05239741
NCT05770102
NCT04812912
NCT06778382
Lead Sponsor
Bayer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions